Development of an isoenzyme-specific colorimetric assay for tissue transglutaminase 2 cross-linking activity

Analytical Biochemistry

Volumn 389, Issue 2, 2009, Pages 150-156

  Perez Alea, Mileidys ^a   Kitamura, Miyako ^b   Martin, Guillaume ^a   Thomas, Vincent ^a   Hitomi, Kiyotaka ^b   El Alaoui, Saïd ^a  

^a Clinical Research Department   (France)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Colorimetric assay; Solid phase assay; Spermine; TG2; TG2 specific assay; Tissue transglutaminase

Indexed keywords

AMINO ACIDS; COLOR; MAMMALS; PROTEINS; TISSUE;

COLORIMETRIC ASSAYS; DOSE-RESPONSE CURVES; FILTER PAPER METHOD; PROTEIN CROSSLINKING; SOLID-PHASE; SPERMINE; STREPTAVIDIN PEROXIDASE; TISSUE TRANSGLUTAMINASE;

COLORIMETRY;

AMIDE; GLUTAMINE; ISOENZYME; LIVER EXTRACT; PEPT26 PROTEIN; PEROXIDASE; PROTEIN DERIVATIVE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; SPERMINE; STREPTAVIDIN; TISSUE TRANSGLUTAMINASE 1; TISSUE TRANSGLUTAMINASE 2; TISSUE TRANSGLUTAMINASE 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLORIMETRY; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS LINKING; DIAGNOSTIC ACCURACY; DOSE RESPONSE; EMBRYO; ENZYME ACTIVITY; FILTER; GUINEA PIG; MEASUREMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

CAVIA;

EID: 67349084359     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2009.03.029     Document Type: Article

References (40)

1. Griffin M., Casadio R., and Bergamini C.M. Transglutaminases: nature's biological glues. Biochem. J. 368 (2002) 377-396
2. Lorand L., and Graham R.M. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat. Rev. Mol. Cell. Biol. 4 (2003) 140-156
3. Fesus L., and Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem. Sci. 27 (2002) 534-539
4. Falasca L., Iadevaia V., Ciccosanti F., Melino G., Serafino A., and Piacentini M. Transglutaminase type II is a key element in the regulation of the anti-inflammatory response elicited by apoptotic cell engulfment. J. Immunol. 174 (2005) 7330-7340
5. Iadevaia V., Rinaldi A., Falasca L., Pucillo L.P., Alonzi T., Chimini G., and Piacentini M. ATP-binding cassette transporter 1 and transglutaminase 2 act on the same genetic pathway in the apoptotic cell clearance. Cell Death Differ. 13 (2006) 1998-2001
6. Nardacci R., Lo Iacono O., Ciccosanti F., Falasca L., Addesso M., Amendola A., Antonucci G., Craxi A., Fimia G.M., Iadevaia V., Melino G., Ruco L., Tocci G., Ippolito G., and Piacentini M. Transglutaminase type II plays a protective role in hepatic injury. Am. J. Pathol. 162 (2003) 1293-1303
7. Shweke N., Boulos N., Jouanneau C., Vandermeersch S., Melino G., Dussaule J.C., Chatziantoniou C., Ronco P., and Boffa J.J. Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration. Am. J. Pathol. 173 (2008) 631-642
8. Stenberg P., Roth E.B., and Sjoberg K. Transglutaminase and the pathogenesis of coeliac disease. Eur. J. Intern. Med. 19 (2008) 83-91
9. Malorni W., Farrace M.G., Rodolfo C., and Piacentini M. Type 2 transglutaminase in neurodegenerative diseases: the mitochondrial connection. Curr. Pharm. Des. 14 (2008) 278-288
10. Falasca L., Farrace M.G., Rinaldi A., Tuosto L., Melino G., and Piacentini M. Transglutaminase type II is involved in the pathogenesis of endotoxic shock. J. Immunol. 180 (2008) 2616-2624
11. Sun Y., Mi W., Cai J., Ying W., Liu F., Lu H., Qiao Y., Jia W., Bi X., Lu N., Liu S., Qian X., and Zhao X. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma. J. Proteome Res. 7 (2008) 3847-3859
12. Hwang J.Y., Mangala L.S., Fok J.Y., Lin Y.G., Merritt W.M., Spannuth W.A., Nick A.M., Fiterman D.J., Vivas-Mejia P.E., Deavers M.T., Coleman R.L., Lopez-Berestein G., Mehta K., and Sood A.K. Clinical and biological significance of tissue transglutaminase in ovarian carcinoma. Cancer Res. 68 (2008) 5849-5858
13. Slaughter T.F., Achyuthan K.E., Lai T.S., and Greenberg C.S. A microtiter plate transglutaminase assay utilizing 5-(biotinamido)pentylamine as substrate. Anal. Biochem. 205 (1992) 166-171
14. de Macedo P., Marrano C., and Keillor J.W. A direct continuous spectrophotometric assay for transglutaminase activity. Anal. Biochem. 285 (2000) 16-20
15. Trigwell S.M., Lynch P.T., Griffin M., Hargreaves A.J., and Bonner P.L. An improved colorimetric assay for the measurement of transglutaminase (type II)-(gamma-glutamyl) lysine cross-linking activity. Anal. Biochem. 330 (2004) 164-166
16. Oertel K., Hunfeld A., Specker E., Reiff C., Seitz R., Pasternack R., and Dodt J. A highly sensitive fluorometric assay for determination of human coagulation factor XIII in plasma. Anal. Biochem. 367 (2007) 152-158
17. Madi A., Karpati L., Kovacs A., Muszbek L., and Fesus L. High-throughput scintillation proximity assay for transglutaminase activity measurement. Anal. Biochem. 343 (2005) 256-262
18. Wu Y.W., and Tsai Y.H. A rapid transglutaminase assay for high-throughput screening applications. J. Biomol. Screen. 11 (2006) 836-843
19. Jeitner T.M., Fuchsbauer H.L., Blass J.P., and Cooper A.J. A sensitive fluorometric assay for tissue transglutaminase. Anal. Biochem. 292 (2001) 198-206
20. Karpati L., Penke B., Katona E., Balogh I., Vamosi G., and Muszbek L. A modified optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma. Clin. Chem. 46 (2000) 1946-1955
21. Thomas V., El Alaoui S., Massignon D., Clement S., Simonet F., and Quash G. Development and evaluation of a modified colorimetric solid-phase microassay for measuring the activity of cellular and plasma (Factor XIII) transglutaminases. Biotechnol. Appl. Biochem. 43 (2006) 171-179
22. Sugimura Y., Hosono M., Wada F., Yoshimura T., Maki M., and Hitomi K. Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: identification of peptide substrates for TGASE 2 and Factor XIIIA. J. Biol. Chem. 281 (2006) 17699-17706
23. K. Hitomi, M. Kitamura, Y. Sugimura, Preferred substrate sequences for transglutaminase 2: screening using a phage-displayed peptide library, Amino Acids (2008).
24. Grossowicz N., Wainfan E., Borek E., and Waelsch H. The enzymatic formation of hydroxamic acids from glutamine and asparagine. J. Biol. Chem. 187 (1950) 111-125
25. Hitomi K., Yamagiwa Y., Ikura K., Yamanishi K., and Maki M. Characterization of human recombinant transglutaminase 1 purified from baculovirus-infected insect cells. Biosci. Biotechnol. Biochem. 64 (2000) 2128-2137
26. Hitomi K., Kanehiro S., Ikura K., and Maki M. Characterization of recombinant mouse epidermal-type transglutaminase (TGase 3): regulation of its activity by proteolysis and guanine nucleotides. J. Biochem. 125 (1999) 1048-1054
27. Sakly W., Thomas V., Quash G., and El Alaoui S. A role for tissue transglutaminase in alpha-gliadin peptide cytotoxicity. Clin. Exp. Immunol. 146 (2006) 550-558
28. Delcros J.G., Bard S., Roch A.M., Quash G., Poupon M.F., and Korach S. Transglutaminase activity and putrescine-binding capacity in cloned cell lines with different metastatic potential. FEBS Lett. 196 (1986) 325-330
29. Curtis C.G., and Lorand L. Fibrin-stabilizing factor (factor XIII). Methods Enzymol. 45 (1976) 177-191
30. Folk J.E., Park M.H., Chung S.I., Schrode J., Lester E.P., and Cooper H.L. Polyamines as physiological substrates for transglutaminases. J. Biol. Chem. 255 (1980) 3695-3700
31. Jeon J.H., Kim C.W., Shin D.M., Kim K., Cho S.Y., Kwon J.C., Choi K.H., Kang H.S., and Kim I.G. Differential incorporation of biotinylated polyamines by transglutaminase 2. FEBS Lett. 534 (2003) 180-184
32. Halling P.J., Ulijn R.V., and Flitsch S.L. Understanding enzyme action on immobilised substrates. Curr. Opin. Biotechnol. 16 (2005) 385-392
33. Zhang J.H., Chung T.D., and Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4 (1999) 67-73
34. Lilley G.R., Griffin M., and Bonner P.L. Assays for the measurement of tissue transglutaminase (type II) mediated protein crosslinking via epsilon-(gamma-glutamyl) lysine and N′,N′-bis (gamma-glutamyl) polyamine linkages using biotin labelled casein. J. Biochem. Biophys. Methods 34 (1997) 31-43
35. Pinkas D.M., Strop P., Brunger A.T., and Khosla C. Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol. 5 (2007) e327
36. Wolvekamp M.C., and de Bruin R.W. Diamine oxidase: an overview of historical, biochemical and functional aspects. Dig. Dis. 12 (1994) 2-14
37. Muriel J.-C.F.M., and Siepaio P. Diamine oxidase and transglutaminase activities in white lupine seedlings with respect to crosslinking of proteins. J. Agric. Food Chem. 43 (1995) 1151-1156
38. Jeon J.H., Lee H.J., Jang G.Y., Kim C.W., Shim D.M., Cho S.Y., Yeo E.J., Park S.C., and Kim I.G. Different inhibition characteristics of intracellular transglutaminase activity by cystamine and cysteamine. Exp. Mol. Med. 36 (2004) 576-581
39. De Laurenzi V., and Melino G. Gene disruption of tissue transglutaminase. Mol. Cell Biol. 21 (2001) 148-155
40. Lorand L., Siefring Jr. G.E., Tong Y.S., Bruner-Lorand J., and Gray Jr. A.J. Dansylcadaverine specific staining for transamidating enzymes. Anal. Biochem. 93 (1979) 453-458